Bendit Technologies Receives FDA Clearance for Bendit17™ Microcatheter

Bendit Technologies, based in Tel Aviv, has obtained FDA clearance for its Bendit17™ Steerable Microcatheter, the smallest of its kind on the market. This approval represents a significant advancement in precision and accessibility for neurovascular and peripheral endovascular interventions.

With this clearance, Bendit's innovative technology will soon be available across the United States. The company plans to begin commercial clinical procedures in January 2026. Moreover, Bendit is working towards securing regulatory clearances in other countries.

The Bendit17 Microcatheter features enhanced steerability and precision, allowing for controlled navigation through complex anatomical structures. Designed for a range of intricate vascular procedures, the device offers improved stability and ease of use for clinicians.